A Texas Instruments sign in Dallas, June 14, 2023.

Katie Tarasov

Elliott, the $65 billion hedge fund best known for its shareholder activism, has made a $2.5 billion investment in Texas Instruments and is urging the company to improve its free cash flow by adapting a less rigid plan for capital expenditures.

Faber Report: Activist Elliott takes $2.5 billion stake in Texas Instruments

In a 13-page letter viewed by CNBC, Elliott proposes that Texas Instruments introduce what it calls a “dynamic capacity-management strategy” that would allow the company to achieve free cash flow of as much as $9 a share by 2026, which is roughly 40% above current consensus of the analysts who follow the world’s largest maker of analog semiconductors.

Shares of TI jumped about 3% on the news before paring back the gains in morning trading.

Elliott believes Texas Instrument’s rigid adherence to a capital expenditure plan put in place in 2022 has eviscerated shareholder returns by greatly reducing a metric by which TI has always asked to be judged– free cash flow.

Citing the reduction of free cash flow from $6.40 a share in 2022 to an expected $1.83 a share this year Elliott maintains that TI has alienated investors who might otherwise gravitate to its dominant position in serving the automotive and industrial complexes with analog chips. Its stock price, Elliott insists, has suffered as a result, trailing its peer group by substantial margins over the last two, four, six and ten year periods.

The focus of Elliott’s letter is the 2022 capital expenditure plan which called for TI to ramp its Capex spending to a high of $5 billion a year from 2023-2026 bringing that spending to as much as 23% of revenues from what had been capex spending of roughly 5% of revenues over the preceding decade.

That allocation of capital will result in the addition of capacity allowing for the company to almost double current annual revenues to $30 billion.

The problem, Elliott maintains, is that a reversal in the cycle of demand for TI’s chips since the plan was put in place will result in capacity levels that are “50% above consensus revenue expectations in 2026 and 2030.”

The letter’s signatories are Jesse Cohn, who runs activism at Elliott and senior portfolio manager Jason Genrich, who has overseen activism efforts in Western Digital, Salesforce and SAP among others. The duo believe the key question for TI’s management and board is not whether TI has a thoughtful long-term strategy but rather: Is the fixed magnitude and pace of its capacity buildout appropriate given the expected level of excess capacity?”

Elliott suggests the company either communicate more forcefully why it believes such an increase in capacity is justified or move to a more dynamic approach to capex in which it builds new fabrication facilities but is more deliberate about equipping them, allowing for a more precise response to market demand.

The letter adapts a far less adversarial tone than is often the case for Elliott, making it seem unlikely the firm will challenge management or the board in a more forceful way in the near term.

In fact, the only threatening passage comes on page 11 in which Elliott charges the board with failing to hold management accountable to one of the company’s core values; prudent capital discipline and urges it to recapture its oversight responsibility by instituting a more dynamic approach to capacity expansion.

A spokesman for Elliott declined to comment on the letter. Representatives from TI could not be reached.

Subscribe to CNBC on YouTube. 

Read More: World News | Entertainment News | Celeb News
CNBC

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Nvidia supplier SK Hynix plans to invest $3.87 billion in U.S. chip facility

SK Hynix logo displayed on a phone screen as seen in this…

The AI trade dominated this week — here’s how we’re responding to the market divergence

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch…

Under Armour is laying off workers as retailer says North America sales will plunge this year

Under Armour announced a broad restructuring plan on Thursday as it said…

Amgen scraps experimental weight loss pill, moves forward with injection

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California,…